Hepatitis B is a DNA, blood borne virus transmitted during infancy, childbirth or blood sharing behaviours (sex, needles)
Hepatitis B presentation is usually asymptomatic in infancy or with acute hepatitis in adulthood
Hepatitis B active infection is from Hepatitis surface antigen and DNA PCR can show viral load
Management: vaccination, tenofovir, liver transplant if Cirrhotic
Hepatitis B is a Double stranded DNA, blood borne virus
Blood borne virus risk factors
Needle stick risk: drug injectors, healthcare workers, tattooes, dental or medical treatment
Unprotected sexual intercourse: MSM (Men who have sex with Men), paid for or paid for sex
Complications:
Cirrhosis - portal hypertension, oesphageal varices, ascites, encephalopathy
Presentation
Infancy
Most commonly in low economic countries
Usually asymptomatic, 90% progress to chronic infection
Vertical transmission- pregnant lady to child exists
Adults
BBV risk factors: unprotected sex, tattoos, injecting drug, healthcare worker
Usually acute hepatitis with 95% clearing without treatment, rare risk of liver failure
RUQ pain, nausea, itch, bruising, lethargy
Examination
Asymptomatic
Liver cirrhosis
RUQ tenderness
Decompensated: jaundice, ascites, oesphageal varices, encephalopathy
Spider naevi, gynaecomastia, ascites
Antibody
HBsAb: +ve = previous vaccination or infection
Anti HBcAb- from current or previous infection
IgG- infection > 6m ago, potentially cleared
IgM- infection within 6 months
AntiHBeAb- positive = active infection, negative = no active infection
Antigen
HBsAg- states whether currently infectious, either active or chronic infection, -ve = no infection
HBcAg- positive = if ever been infected- current or previous infection
HBeAg- positive = highly infectious
Other investigations
LFTs: transaminitis (ALT > AST)
HCC surveillance- liver USS + AFP
OGD ? varices
Lifestyle
Partner wear condoms & HBV vaccination
HCC surveillance: 6 monthly AUSS & AFP (if criteria met, i.e. cirrhotic)
Medical
Watch & Wait
Tenofovir - lifelong, once risk of cirrhosis & HCC outweighs side effects
Other medications- e.g. interferon
Surgical
Liver Transplant
Investigation Patterns
Nil infection/ vaccination: negative throughout
Immune due to vaccination: antiHBsAg only
Cleared infection: AntiHBsAg, AntiHBcAg IgG (if > 6m nil anti-HBcAg IgM)
Active infection: antiHBcAg (IgM & IgG), HBcAg & HBsAg; nil antiHBsAg (B cell dysfunction)
Chronic infection: AntiHBcAg & HBsAg
Tenofovir is usually continued for life once started. Started once benefits > risks. Usually in late to middle age once immune system weakens with age and viral load increases.
Benefits: reduces the progression to cirrhosis & rates of HCC
Indications to treat: high viral load, raised AST/ cirrhosis
Side effects: nausea, headaches, lethargy
Complications: Renal Impairment, Osteoporosis
Monitoring: bloods with urine P:Cr
Breast feeding: safe
Indications similiar to tenofovir treatment. Because of effective screening tests and treatments (TACE), low threshold for
Indications:
Tenofovir treatment,
Cirrhosis,
High viral load,
> 20 year & african ethnicity or > 50 years & asian ethnicity
6 monthly AUSS and AFP
All Babies in UK will get routine HBV vaccination.
Vertical transmission considered a never event
If HBV copies > 100,000: treatment with tenofovir, HBV vaccination & Immunoglobulin booster
Legal responsibility of individual to inform partner
Healthcare worker can break confidentiality to inform partner or workplace if significant risk of harm
Advice partner to be vaccinated & wear condoms
HBV: 0.3% risk per needle stick
High risk events (needlestick in known or high risk HBV)
Give HBV immunoglobulin within first 12 hours, nil value > 7d
Test for HBV
Consider PEP
Low risk events- minimal needlestick in low risk individual:
Test for HBV
Await PEP till after tests
Summary
Diagnosis:
Asymptomatic screening
Acute Hepatitis- may require admission
Monitoring in clinic: as there is no cure, these individuals often require long periods of monitoring in clinics.
Clinic Checklist
Investigations
LFTs- AST
Hepatitis B surface antigen & viral load
Hepatitis D co-infection
Fibroscan ? cirrhosis, AUSS ? HCC
Management
Support / job- vaccination self / partner
Decision to treat / referral for transplant
Body Systems: Gastrointestinal
Pathology: Infectious
Examinations: Gastrointestinal & Liver Exam
Specialties: Gastroenterology, Infectious Diseases, Sexual Health
Written in 2026.